C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2009
11/26/2009	US20090291439 Phosphatases involved in the regulation of cardiomyocyte differentiation
11/26/2009	US20090291428 Compositions and methods for the detection and treatment of poxviral infections
11/26/2009	US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof
11/26/2009	US20090291094 Antibodies and processes for preparing the same
11/26/2009	US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
11/26/2009	US20090291085 Human estrogen receptor specific immunoglobulin for use in treatment and prevention of cell proliferative disorders
11/26/2009	US20090291084 Anti- il-6 antibodies, compositions, methods and uses
11/26/2009	US20090291083 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/26/2009	US20090291081 Dual-specific IL-1A/IL-1b antibodies
11/26/2009	US20090291080 Levels of april in serum and use in diagnostic methods
11/26/2009	US20090291078 Glyco-engineered antibodies
11/26/2009	US20090291075 Binding agents and their use in targeting tumor cells
11/26/2009	US20090291048 Leukocyte-binding polypeptides and uses thereof
11/26/2009	CA2725169A1 Method of generating single vl domain antibodies in transgenic animals
11/26/2009	CA2725154A1 Methods of treatment utilizing binding proteins of the interleukin-21 receptor
11/26/2009	CA2724915A1 Interleukin-21 receptor binding proteins
11/26/2009	CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	CA2724780A1 Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm
11/26/2009	CA2724717A1 Methods, devices, kits and compositions for detecting roundworm
11/26/2009	CA2723618A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
11/25/2009	EP2123763A1 Compositions and methods of increasing stress tolerance in plants
11/25/2009	EP2123751A1 Novel peptide
11/25/2009	EP2123749A2 Novel genes encoding novel proteolytic enzymes
11/25/2009	EP2123679A2 Tyrosine phosphorylation sites
11/25/2009	EP2123678A1 Identifying acceptor germline sequences for humanized antibodies
11/25/2009	EP2123677A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
11/25/2009	EP2123676A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody
11/25/2009	EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123302A1 Chronic rejection inhibitor
11/25/2009	EP2123299A1 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody
11/25/2009	EP2123297A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
11/25/2009	EP2121762A1 BINDING MEMBERS FOR IgE MOLECULES
11/25/2009	EP2121761A1 He4 monoclonal antibodies and methods for their use
11/25/2009	EP2121760A2 Antibodies to cd200r
11/25/2009	EP2121759A2 huTNFR1 SELECTIVE ANTAGONISTS
11/25/2009	EP2121758A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists
11/25/2009	EP2121757A2 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
11/25/2009	EP2121756A1 Antibodies and methods for making and using them
11/25/2009	EP2121755A1 Antibodies specific for dkk-1
11/25/2009	EP2121754A1 Pegylated a fab
11/25/2009	EP2121753A2 Method of isolating antibodies by precipitation
11/25/2009	EP2121752A1 Method for increasing protein yields
11/25/2009	EP2121751A2 Monoclonal antibodies against angptl3
11/25/2009	EP2121750A2 Inflammation treatment, detection and monitoring via trem-1
11/25/2009	EP2121738A2 Proteins
11/25/2009	EP2121019A1 A new immunoglobulin against helicobacter pylori
11/25/2009	EP2121014A2 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
11/25/2009	EP2121008A2 Uses of monoclonal antibody 8h9
11/25/2009	EP2120997A2 Modulation of activity of proneurotrophins
11/25/2009	EP2120915A2 Polyelectrolyte precipitation and purification of antibodies
11/25/2009	EP1325033B1 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
11/25/2009	EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	CN101589063A Humanized anti-factor D antibodies and uses thereof
11/25/2009	CN101589062A Compositions and methods relating to glucagon receptor antibodies
11/25/2009	CN101589061A Antibody molecules which bind IL-17A and IL-17F
11/25/2009	CN101589060A Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
11/25/2009	CN101589059A Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589058A Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589057A Amino acid sequences that bind to a desired molecule in a conditional manner
11/25/2009	CN101588817A Fully human high yield production system for improved antibodies and proteins
11/25/2009	CN101586106A The genome of the hiv-1 inter-subtype (c/b') and use thereof
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585880A Variable regions on heavy and light chains of antihuman IL-13R alpha 2 monoclonal antibodies
11/25/2009	CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009	CN100562570C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
11/25/2009	CN100562339C Remedies for infact chronic arthritis-relating diseases
11/24/2009	US7622635 Method of increasing yield in plants
11/24/2009	US7622569 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/24/2009	US7622560 Expressed on human acute leukemia, lymphoblastic lymphoma cells, but not on mature hematopoietic cells, hematopoietic stem cells and non-hematopoietic cells; kits; immunohistochemistry
11/24/2009	US7622559 Chemokine specific immunoglobulin for prevention and treatment of cell proliferative, skin, inflammatory and autoimmune disorders
11/24/2009	US7622558 Hybridomas, cell lines; solid phase synthesis
11/24/2009	US7622557 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622555 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622444 Methods for using OX-40 ligand to enhance an antigen specific immune response
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622270 Methods of isolating dopaminergic neuron precursor cells
11/24/2009	US7622262 Uses of Gangliosides GM1 and/or asialo-GM1 substances simulating the carbohydrate portion of the gangliosides; early diagnosis of cancer; carcinoma
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622118 Cancer treatment methods using selected antibodies to aminophospholipids
11/24/2009	US7622116 Method of treating inflammation using soluble IL-17RCX4
11/24/2009	US7622115 Treatment with anti-VEGF antibodies
11/24/2009	US7622113 Monoclonal antibodies that bind or neutralize dengue virus
11/24/2009	US7622112 Anti-SARS monoclonal antibodies
11/24/2009	US7622111 Fusion protein of human IgG1 heavy chain constant region and scFv antibody against equine encephalitis virus
11/24/2009	US7622110 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis
11/24/2009	US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents
11/24/2009	US7622100 Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
11/24/2009	CA2474880C Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
11/24/2009	CA2445046C Nitrilases
11/24/2009	CA2374513C Il-1 eta dna and polypeptides
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/19/2009	WO2009140623A2 Anti-psgl-1 antibodies and methods of identification and use
11/19/2009	WO2009140361A1 ANTI-PirB ANTIBODIES
11/19/2009	WO2009140177A2 Anti-fn14 antibodies and uses thereof

1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 1494